Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

Market Cap	7.38B +2.6%
Revenue (ttm)	2.86B +31.4%
Net Income	132.41M -30.1%
EPS	0.53 -35.4%
Shares Out	249.40M
PE Ratio	55.81
Forward PE	25.36
Dividend	0.16 (0.54%)
Ex-Dividend Date	Jul 10, 2025

Volume	4,070,310
Average Volume	7,306,242
Open	29.36
Previous Close	29.58
Day's Range	29.18 - 30.48
52-Week Range	25.60 - 43.60
Beta	0.03
RSI	35.80
Earnings Date	Mar 18, 2026

About SHA:688639

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-pantothenate calcium, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical produ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 2,191
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688639

Financial Performance

In 2025, SHA:688639's revenue was 2.86 billion, an increase of 31.40% compared to the previous year's 2.18 billion. Earnings were 132.41 million, a decrease of -30.13%.